SINOPHARM GROUP CO LTD ADR share price logo

SINOPHARM GROUP CO LTD ADR

NASDAQ: SHTDY

Mid Cap

$10.88

-0.13

(-1.16%)

as on

SINOPHARM GROUP CO LTD ADR Stock Performance

as on June 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $10.84
    $10.97
    downward going graph

    0.37%

    Downside

    0.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

SINOPHARM GROUP CO LTD ADR share price movements today

Previous Close
$11.01
Open
$10.95
Volume
305.3K
Day's Low - High
$10.84 - $10.97

SINOPHARM GROUP CO LTD ADR Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

SINOPHARM GROUP CO LTD ADR Stock Fundamentals & Key Indicators

Check SINOPHARM GROUP CO LTD ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.8B

EPS (TTM)

0

Dividend Yield

4.35%

PE Ratio (TTM)

6.4

Industry PE ratio

9.44

PEG Ratio

2.2575

Return On Equity TTM

8.10%

SINOPHARM GROUP CO LTD ADR Stock Valuation

Track how SINOPHARM GROUP CO LTD ADR P/E has moved over time to understand its valuation trends.

SINOPHARM GROUP CO LTD ADR in the last 5 years

  • Overview

  • Trends

Lowest (2.20x)

September 30, 2025

Today (6.40x)

June 5, 2026

Industry (9.44x)

June 5, 2026

Highest (9.86x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 6.40x

SINOPHARM GROUP CO LTD ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SINOPHARM GROUP CO LTD ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SINOPHARM GROUP CO LTD ADR image
SINOPHARM GROUP CO LTD ADR
NA$6.8BNA6.41.24%4.35%
Cardinal Health Inc image
Cardinal Health Inc
HOLD$45.9B256.68%29.950.62%1.05%
McKesson Corporation image
McKesson Corporation
BUY$88.9B288.3%19.271.18%0.43%
Henry Schein Inc image
Henry Schein Inc
HOLD$8.6B-2.05%22.882.95%NA
Cencora Inc. image
Cencora Inc.
BUY$51.3B114.69%20.20.78%0.8699999999999999%

SINOPHARM GROUP CO LTD ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
145,765
145,517
300,950
19,864
295,619
147,265
294,726
289,781
286,042
283,784
Gross Profit
25,776
10,940
23,270
1,634
25,240
10,575
21,943
22,312
20,775
20,695
Operating Income
13,251
4,014
9,833
3,464
10,375
3,386
8,221
7,966
7,141
9,045
EBITDA
7,240
4,517
10,907
4,527
13,496
3,907
9,527
10,647
9,934
11,062
Interest Expense
1,266
-
-
512
-
-
965
1,137
457
1,221
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
5,973
3,637
8,866
4,160
10,646
3,123
7,596
6,404
7,198
7,449
Income Tax Expense
1,440
827
1,972
987
2,529
724
1,697
1,880
1,869
2,053
Net Income
4,831
1,590
4,104
272
4,949
1,420
3,703
3,345
3,457
3,621
Net Profit Margin
3.31%
1.09%
1.36%
1.37%
1.67%
0.96%
1.26%
1.15%
1.21%
1.28%

SINOPHARM GROUP CO LTD ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
37,322
41,991
50,009
60,633
69,778
81,817
79,123
83,540
584,507
559,497
Gross Profit
2,949
3,393
4,532
5,351
6,164
6,917
6,797
6,793
44,255
40,094
Operating Income
10,213
11,905
15,396
16,136
17,759
19,711
20,604
20,209
16,188
16,212
EBITDA
12,036
13,431
16,672
20,316
22,619
24,682
26,249
26,898
20,174
20,384
Interest Expense
2,043
2,611
4,157
3,442
3,424
3,756
3,520
2,956
2,734
2,427
Depreciation
-
1,015
1,394
3,114
3,597
3,922
4,165
4,430
4,733
4,289
Income Before Tax
8,924
10,173
12,207
13,759
15,598
17,003
18,563
19,512
14,000
14,396
Income Tax Expense
2,033
2,304
2,803
3,139
3,500
3,938
4,218
4,502
3,577
3,857
Net Income
671
1,192
1,365
1,514
1,098
1,218
1,221
1,267
7,049
6,960
Net Profit Margin
1.80%
2.84%
2.73%
2.50%
1.57%
1.49%
1.54%
1.52%
1.21%
1.24%

SINOPHARM GROUP CO LTD ADR Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
4,104
1,991
4,949
1,420
3,703
1,574
3,345
3,457
11,341
Operating Cash Flow
-43,326
3,656
60,499
-47,481
-40,993
-
52,539
-34,111
48,249
Investing Cash Flow
1,180
-1,167
-957
256
-1,038
-
-2,712
-531
-432
Financing Cash Flow
21,295
-3,609
-28,939
22,154
21,551
-
-38,836
15,579
-34,265
Change in Cash
-20,844
-1,116
30,548
-25,069
43,331
-
-43,331
35,238
13,557

SINOPHARM GROUP CO LTD ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
10,173
12,207
13,759
15,598
17,003
18,563
19,512
14,000
14,799
Operating Cash Flow
1,667
3,653
18,777
11,154
9,308
20,963
17,173
11,546
14,138
Investing Cash Flow
-2,547
-5,907
-6,795
-2,202
-1,266
-3,589
-944
-3,750
-963
Financing Cash Flow
4,302
10,318
-13,084
2,025
-14,693
-5,693
-7,643
-17,285
-18,686
Change in Cash
3,438
8,058
-1,107
10,986
-6,648
11,692
8,586
-9,495
-5,517

Insights on SINOPHARM GROUP CO LTD ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SHTDY stock has moved up by 1.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 3.34B → 3.62B (in $), with an average increase of 3.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Cardinal Health, Inc. has given 147.0% return, outperforming this stock by 180.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Cardinal Health, Inc. has given 33.0% return, outperforming this stock by 40.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 294.72B → 283.78B (in $), with an average decrease of 1.3% per quarter

About SINOPHARM GROUP CO LTD ADR

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
OrganisationSINOPHARM GROUP CO LTD ADR
HeadquartersSinopharm Group Building, Shanghai, China, 200023
IndustryMedical Distribution
CEOMr. Wanyong Lian
E-voting on sharesClick here to vote

Key Management of SINOPHARM GROUP CO LTD ADR

Name

Title

Mr. Yijian Wu

VP, Secretary to the Board & Company Secretary

Mr. Wanyong Lian

President & Executive Director

Mr. Binghua Yang

Executive Director

Ms. Xiaojuan Li

Chief Financial Officer

FAQs

What is SINOPHARM GROUP CO LTD ADR share price today?

SINOPHARM GROUP CO LTD ADR share price today is $10.88 as on at the close of the market. SINOPHARM GROUP CO LTD ADR share today touched a day high of $10.97 and a low of $10.84.

What is the 52 week high and 52 week low for SINOPHARM GROUP CO LTD ADR share?

SINOPHARM GROUP CO LTD ADR share touched a 52 week high of $0 on and a 52 week low of $0 on . SINOPHARM GROUP CO LTD ADR stock price today i.e. is closed at $10.88,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is SINOPHARM GROUP CO LTD ADR's market capitalisation today?

SINOPHARM GROUP CO LTD ADR market capitalisation is $0.01T as on .

How to invest in SINOPHARM GROUP CO LTD ADR Stock (SHTDY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for SINOPHARM GROUP CO LTD ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SINOPHARM GROUP CO LTD ADR Shares that will get you 0.1379 shares as per SINOPHARM GROUP CO LTD ADR share price of $10.88 per share as on June 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy SINOPHARM GROUP CO LTD ADR Stock (SHTDY) from India?

Indian investors can start investing in SINOPHARM GROUP CO LTD ADR (SHTDY) shares with as little as ₹94.95 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in SINOPHARM GROUP CO LTD ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on SINOPHARM GROUP CO LTD ADR share’s latest price of $10.88 as on June 6, 2026 at 1:29 am IST, you will get 0.9191 shares of SINOPHARM GROUP CO LTD ADR. Learn more about fractional shares .